The growing volume of diabetes-related dialysis: A population based study

Nephrology Dialysis Transplantation

Volumn 19, Issue 12, 2004, Pages 3098-3103

  Lok, Charmaine E ^a,b   Oliver, Matthew J ^c   Rothwell, Deanna M ^b   Hux, Janet E ^b,c  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Diabetes; Dialysis; Population study; Survival

Indexed keywords

AGE; ARTICLE; CANADA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIALYSIS; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE;

COHORT STUDIES; COMORBIDITY; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; UNITED STATES;

EID: 11244300812     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh540     Document Type: Article

References (20)

1. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. J Am Med Assoc 1997; 278: 2069-2074
2. Perneger TV, Brancati FL, Whelton PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 1994; 121: 912-918
3. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. J Am Med Assoc 2003; 290: 1884-1890
4. US Renal Data System. USRDS 2003 Annual Data Report: Atlas of Endstage Renal Disease in the United States. National Institues of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Betheseda, MD; 2003
5. CORR Preliminary Report. www.cihi.ca, 2002
6. Hox JE, Ivis F, Flintoft V, Bica A. Diabetics in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516
7. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 337-342
8. Lee ET, Lee VS, Lu M, Lee JS, Russell D, Yeh J. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes 1994; 43: 572-579
9. Pugh JA, Medina RA, Cornell JC, Basu S. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community. Diabetes 1995; 44: 1375-1380
10. UK Renal Registry Report. UK Renal Registry, Bristol
11. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. [erratum appears in Br Med J 1999 Jan 2; 318 (7175): 29]. Br Med J 1998; 317: 703-713
13. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462
14. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581
15. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. J Am Med Assoc 1996; 276: 1409-1415
16. Disney APS, Russ GR, Walker R, Sheil AGR, eds. ANZDATA Registry Report 1997. Australia and New Zealand Dialysis and Transplant Registry, Adelaide; 1998
17. Kikkawa R, Kida Y, Haneda M. Nephropathy in type II diabetes - epidemiological issues as viewed from Japan. Nephrol Dial Transplant 1998; 13: 2743-2745
18. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1997; 8: 965-971
19. Wong JS, Port FK, Hulbert-Shearon TE et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55: 2515-2523
20. Miskulin DC, Meyer KB, Athienites NV et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39: 324-336